TrialThe Journal of infectious diseases2024

Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB-Containing Vaccines.

Spyros Chalkias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.